SEC Form 4 · accession 0001144204-16-093760
ANI PHARMACEUTICALS INC · ANIP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James G. Marken
Officer — Vice President, Operations
Period of report
Apr 7, 2016
Accepted (ET)
Apr 11, 2016 · 7:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001023024
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 7, 2016 | A | 1,875 | $0.00 | A | 47,858 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to PurchaseF2,F3 | $40.59 | Apr 7, 2016 | A | 3,750 | A | — | Apr 6, 2026 | Common Stock | 3,750 | 3,750 | D |
Explanation of responses
- F1On April 7, 2016, the Board of Directors of the Issuer approved the grant of restricted stock, which vest in equal annual installments on the first, second, third and fourth anniversaries of the grant date.
- F2The closing price of the Issuer's common stock on The NASDAQ Global Market on the grant date.
- F3The options vest in an equal annual amount over a four-year period beginning on the first anniversary of the grant date.